Merck & Co (NYSE:MRK) reported quarterly earnings results on February 03, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.04, beating the consensus estimate of $2.02 by $0.02 per share. Revenue came in at $16.4B, beating the estimate of $16.2B.
Merck & Co's stock moved following the earnings release. The stock currently trades at $119.09 with a market capitalization of $248.8B.
